[The role of internal medicine in preventing stroke in atrial fibrillation]

Med Clin (Barc). 2012 Oct:139 Suppl 2:36-40. doi: 10.1016/S0025-7753(12)70040-4.
[Article in Spanish]

Abstract

Atrial fibrillation (AF) is the most frequent supraventricular arrhythmia in our environment. The incidence and prevalence of this disease increase with age and with the presence of concomitant cardiovascular disorders; consequently, AF is frequently encountered in the field of internal medicine. Elderly patients have a series of characteristics that lead to a high risk of thromboembolic complications and hemorrhagic events. Internal medicine specialists should be trained in the global management of this disease, in order to correctly evaluate the risk of complications and take unusually difficult decisions. The new oral anticoagulants provide an interesting and promising alternative in the prevention of AF-related stroke, although there are several limitations to consider before prescribing these agents in this group of patients.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications*
  • Benzimidazoles / therapeutic use
  • Dabigatran
  • Decision Support Techniques
  • Humans
  • Internal Medicine*
  • Morpholines / therapeutic use
  • Pyrazoles / therapeutic use
  • Pyridones / therapeutic use
  • Risk Assessment
  • Rivaroxaban
  • Stroke / etiology
  • Stroke / prevention & control*
  • Thiophenes / therapeutic use
  • beta-Alanine / analogs & derivatives
  • beta-Alanine / therapeutic use

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Pyrazoles
  • Pyridones
  • Thiophenes
  • beta-Alanine
  • apixaban
  • Rivaroxaban
  • Dabigatran